PICKERING, ONTARIO--(MARKET WIRE)--Jun 22, 2006 -- Sergio Martines, President and C.E.O. of NSP Pharma Corp. ("NSP") (TSX VENTURE:NSP.V - News) confirms that the Board of Directors of NSP has accepted the resignation of Denis Arseanault as a Board member, on June 21, 2006. Mr. Arsenault is presently the Chief Financial Officer and a Director of Orbus Pharma Inc. (TSX:ORB.TO - News), and has been a director of NSP and the chairman of the audit committee since inception of NSP. The Board of Directors wishes to express its appreciation for his assistance during his tenure.
